Notice on the 2nd Extraordinary General Meeting in 2025
Filed with SSE · · 6 pages · Chinese
Nanjing Vazyme Biotech Co., Ltd. on 6ix
Earlier from Nanjing Vazyme Biotech
- Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificate by Wholly-owned Subsidiary
- Announcement on By-election of Non-independent Director
- Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificate for Subsidiary’s Product
- Announcement on Shareholding Reduction Plan for Shareholders with Over 5% Shares
- Announcement on Initially Repurchasing the Company's Shares through Call Auction
Later from Nanjing Vazyme Biotech
- Announcement on Election of Employee Director
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
- Announcement on Voluntary Disclosure of Obtaining EU CE IVDR Certification for the Company's Products
- Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1% Scale
- Announcement on Expiration of Shareholding Reduction Plan and Results of Shareholders
Follow Nanjing Vazyme Biotech into a list and get an email when it puts out news.
Follow Nanjing Vazyme Biotech